We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Brookdale Senior Living
BKD
$3.71B
| $2.78M | ﹤0.01% |
650,077
+204,757
| +46% | +$970K |
|
|
LBC
427
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $2.74M | ﹤0.01% |
236,178
-3,670
| -2% | -$47.2K |
|
428
Heritage Financial
HFWA
$1.23B
| $2.73M | ﹤0.01% |
102,995
+6,026
| +6% | +$159K |
|
429
IBEX
IBEX
$468M
| $2.72M | ﹤0.01% |
146,665
-2,816
| -2% | -$49.3K |
|
430
Hope Bancorp
HOPE
$1.76B
| $2.64M | ﹤0.01% |
209,245
+57,276
| +38% | +$829K |
|
|
HNGR
431
DELISTED
Hanger Inc.
HNGR
| $2.6M | ﹤0.01% |
138,754
-11,569
| -8% | -$205K |
|
432
AllianceBernstein
AB
$3.5B
| $2.53M | ﹤0.01% |
72,149
-2,414
| -3% | -$102K |
|
433
James River Group Holdings
JRVR
$220M
| $2.53M | ﹤0.01% |
110,865
-3,574
| -3% | -$85.3K |
|
434
First Internet Bancorp
INBK
$230M
| $2.5M | ﹤0.01% |
73,790
-2,378
| -3% | -$86.6K |
|
|
ONTF
435
DELISTED
ON24
ONTF
| $2.47M | ﹤0.01% |
281,128
+146,106
| +108% | +$1.4M |
|
436
Apple Hospitality REIT
APLE
$4B
| $2.47M | ﹤0.01% |
175,420
-9,000
| -5% | -$143K |
|
|
MNTV
437
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $2.46M | ﹤0.01% |
423,974
+350,847
| +480% | +$2.73M |
|
438
Linde
LIN
$237B
| $2.36M | ﹤0.01% |
8,754
+878
| +11% | +$252K |
|
|
EQC
439
DELISTED
Equity Commonwealth
EQC
| $2.33M | ﹤0.01% |
+95,802
| New | +$2.58M |
|
440
Entravision Communication
EVC
$995M
| $2.32M | ﹤0.01% |
585,069
+80,845
| +16% | +$400K |
|
441
Primis Financial Corp
FRST
$391M
| $2.31M | ﹤0.01% |
190,843
-4,682
| -2% | -$61.9K |
|
442
First Mid Bancshares
FMBH
$1.37B
| $2.29M | ﹤0.01% |
71,669
-2,314
| -3% | -$83.8K |
|
443
Boston Scientific
BSX
$68.8B
| $2.23M | ﹤0.01% |
57,588
+422
| +0.7% | +$16.9K |
|
|
SF
444
Stifel
SF
$12.4B
| $2.18M | ﹤0.01% |
63,033
+1,258
| +2% | +$49.5K |
|
445
Perella Weinberg Partners
PWP
$1.19B
| $2.15M | ﹤0.01% |
339,027
-222
| -0.1% | -$1.58K |
|
446
Newmark Group
NMRK
$2.84B
| $2.14M | ﹤0.01% |
265,843
+21,921
| +9% | +$226K |
|
447
Arcos Dorados Holdings
ARCO
$1.77B
| $2.14M | ﹤0.01% |
293,201
+63,394
| +28% | +$456K |
|
448
Baidu
BIDU
$35.2B
| $2.02M | ﹤0.01% |
17,183
+5,341
| +45% | +$729K |
|
449
Apple
AAPL
$5.02T
| $2.01M | ﹤0.01% |
14,528
-1,932
| -12% | -$303K |
|
|
AVTA
450
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.96M | ﹤0.01% |
101,216
-50,664
| -33% | -$1.02M |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.